MedPath

A clinical trail to study the effects of karappan kudineer chooranam (internal) and karappan ennai (external ) in patients with sattai karappan

Phase 2
Not yet recruiting
Conditions
sattai karappan
Registration Number
CTRI/2018/07/014869
Lead Sponsor
A AMMU
Brief Summary

The study is  prospective open labeled non randomized phase 2 an open clinical study to evaluate the clinical efficacy of siddha sasthric formulation Karappan kudineer chooranam(internal) Karappan ennai (external) 3-7 years 30ml,7-12years 60ml,twice a day (morning and evening)internally and Oil-externally for 21 days in 40 patients during the trail period of 13months that will be conducted in government siddha medical college and hospital palayamkottai Tamil nadu The primary outcome will be the therapeutic efficacy of trial drug Karappan kudineer chooranam(internal) karappan ennai(external)on Sattai karappan The secondary outcome will be the evaluation of siddha diagnostic parameters

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Patient with appropriate symptoms of intense itching erythema papules papulovesicles crusted lesion all over the body ulceration exudation constipation.

Exclusion Criteria

children above 12 years scabies psoriasis secondary bacterial infection nummular dermatitis contact dermatitis seborric dermatitis furunculosis photo dermatitis neuro dermatitis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the therapeutic efficacy of trial drug Karappan kudineer chooranam(internal)karappan ennai (external)on Sattai karappan21 days
Secondary Outcome Measures
NameTimeMethod
Evaluation of siddha diagnostic parameters21 days

Trial Locations

Locations (1)

Goverment siddha medical college and hospital

🇮🇳

Tirunelveli, TAMIL NADU, India

Goverment siddha medical college and hospital
🇮🇳Tirunelveli, TAMIL NADU, India
A AMMU
Principal investigator
9629847962
madhi1493@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.